From: Model composition through model reduction: a combined model of CD95 and NF-κB signaling pathways
Species | Reactions | The role in the apoptosis process |
---|---|---|
CD95L | br1* | Triggering the apoptosis process. |
DISC | br2* | Activation of caspase-8 in the DISC complex. In the case of a high ligand concentration, DISC is a slow species, so reactions br1* and br2* cannot be combined. |
caspase-3 | br3* | Activation of caspase-8 via the negative-feedback loop. When the concentration of CD95L is reduced, the rate of br3* is an order of magnitude higher than the rate of br2*. Thus, activation of caspase-8 is mainly caused by caspase-3. |
br8* | Cleavage/activation of procaspase-2 is confirmed by the experimental data. | |
br9* | Caspase-3 activation plays a crucial role in the cleavage of procaspases-2, -8 and PARP. | |
br11* | PARP inactivation is confirmed by the experimental measurements of PARP and cPARP concentrations. | |
cFLIP | br4* | Inhibition of the DISC complex. cFLIP blocks the activity of DISC preventing a significant increase of caspase-8 concentration. This conclusion is consistent with the observations by Bentele et al. asserting that down-regulation of cFLIP resulted in cell death occurring already upon low concentration of anti-CD95 (1 ng/ml). |
DISC:cFLIP:pro8 | br5* | Production of blocked p43/p41, whose concentration is detected by the experimental data. |
br6*, br7*, br10* | Activation of Bid and cleavage of procaspases-7 and −9. These reactions determine dynamics of the mentioned species in agreement with the experimental data. | |
IAP | br12* | Inhibition of caspase-3. In the case of the reduced activation scenario, IAP prevents caspase-3 from reaching a significant level and, therefore, blocks significant increase of caspase-8 due to br3*. |
x aa | br13* | The virtual variable x aa specifies the process of degradation. |